- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x 1S5: 5-(4-amino-2-methylphenoxy)-2-hexyl-4-hydroxy-1-methylpyridinium(Non-covalent)
1S5.2: 14 residues within 4Å:- Chain A: G.93, F.94, A.95, I.100, Y.146, P.154, N.155, Y.156, M.159, K.163, I.200, F.203, I.206
- Ligands: NAI.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.100, A:Y.146, A:Y.146, A:Y.146, A:N.155, A:Y.156, A:Y.156, A:Y.156, A:I.206
- Hydrogen bonds: A:A.95, A:A.95
1S5.4: 14 residues within 4Å:- Chain B: G.93, F.94, A.95, I.100, Y.146, P.154, N.155, Y.156, M.159, K.163, I.200, F.203, I.206
- Ligands: NAI.3
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:I.100, B:Y.146, B:Y.146, B:Y.146, B:N.155, B:Y.156, B:Y.156, B:Y.156, B:I.206
- Hydrogen bonds: B:A.95, B:A.95
1S5.6: 14 residues within 4Å:- Chain C: G.93, F.94, A.95, I.100, Y.146, P.154, N.155, Y.156, M.159, K.163, I.200, F.203, I.206
- Ligands: NAI.5
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:I.100, C:Y.146, C:Y.146, C:Y.146, C:N.155, C:Y.156, C:Y.156, C:Y.156, C:I.206
- Hydrogen bonds: C:A.95, C:A.95, C:Y.156
1S5.8: 14 residues within 4Å:- Chain D: G.93, F.94, A.95, I.100, Y.146, P.154, N.155, Y.156, M.159, K.163, I.200, F.203, I.206
- Ligands: NAI.7
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:I.100, D:Y.146, D:Y.146, D:Y.146, D:N.155, D:Y.156, D:Y.156, D:Y.156, D:I.206
- Hydrogen bonds: D:A.95, D:A.95, D:Y.156
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (Acp) Reductase Inhibitor. J.Biol.Chem. (2014)
- Release Date
- 2014-04-09
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x 1S5: 5-(4-amino-2-methylphenoxy)-2-hexyl-4-hydroxy-1-methylpyridinium(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (Acp) Reductase Inhibitor. J.Biol.Chem. (2014)
- Release Date
- 2014-04-09
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A